Zyrtec, azithromycin Camptosar and Norvasc fourth-quarter 2008
revenues decreased by $515 cyclobenzaprine is an antibiotic i million ($263 million, $144 million and $108
million, respectively), compared with the year-ago quarter. PFE - News) today reported financial results for
fourth-quarter and full-year 2008. This decrease
azythromycin∞
was primarily antibiotic attributable to
the negative buy amoxicillin antibiotic online impact of the loss of U.S. For fourth-quarter 2008, the Company
recorded reported revenues valacyclovir sanford guide of $12.3 billion,
prescription medicines∞
a decrease of 4% compared
with the year-ago quarter. Exclusivity for
amoxicillin and potassium clavulanate∞
Zyrtec in
and for Camptosar in as well antibiotics in the united states as the loss of
exclusivity
azythromycin∞
antibiotics for Norvasc in Korea and Japan in and July
2008, respectively.
($
genital herpes∞
in millions, except per share macrobid antibiotic sinus infection amounts)
Fourth-Quarter
Full-Year
trysul antibiotic
2008
2007
Change
2008
antibiotics azithromycin with cefalosporin
2007
Change
Reported Revenues
$ 12,346
$ 12,870
azythromycin
(4%)
$ 48,296
zithromax pet antibiotic sinus
$ 48,418
--
Reported Net Income
266
2,724
quinolone antibiotics uses
(90%)
8,104
8,144
--
Reported Diluted EPS
0.04
0.40
antibiotic ointment boots
(90%)
1.20
1.17
3%
Adjusted Revenues(1)
12,311
12,795
(4%)
48,341
48,209
--
Adjusted Income(1)
4,389
3,402
29%
16,366
15,113
8%
Adjusted Diluted EPS(1)
tetracycline for rabbit 0.65
0.50
30%
dapoxetine sildenafil viagra tadalafil azithromycin
2.42
2.18
11%
See end of text prior to tables for notes. In addition,
foreign exchange unfavorably impacted.